Table 2 Distribution of clinically significant CMA findings in fetuses with isolated and non-isolated polyhydramnios
From: Evaluation of genetic variants using chromosomal microarray analysis for fetuses with polyhydramnios
| Â | Karyotype-detectable | CMA-detectable only | Total (%) | ||
|---|---|---|---|---|---|
T21 (%) | T18 (%) | CNVs (P + LP) (%) | LOH (%) | ||
Isolated (N = 39) | 0, 0.0 | 0, 0.0 | 1, 2.6 | 0, 0.0 | 1, 2.6 |
Non-isolated(N = 111) | 3, 2.7 | 3, 2.7 | 8, 7.2 | 1, 0.9 | 15, 13.5 |
soft markers (n = 59) | 1, 1.7 | 0, 0.0 | 3, 5.1 | 0, 0.0 | 4, 6.8 |
Non-soft markers (n = 52) | 2, 3.8 | 2, 3.8 | 5, 9.6 | 1, 1.9 | 10, 19.2 |
Total | 3, 2.0 | 3, 2.0 | 9, 6.0 | 1, 0.7 | 16, 6.7 |